Home
E-Submission
Sitemap
Contact Us
HOME
ABOUT
Aims and scope
About the journal
Editorial board
Principles of transparency and best practice
Management team
Open access
Subscription information
Contact us
BROWSE ARTICLES
All issues
Current issue
Ahead-of print articles
Most read articles
Most download articles
Most cited articles
Search
Author index
FOR AUTHORS AND REVIEWERS
Instructions for authors
Research and publication ethics
Author checklist
E-submission
Submission requirement form
Search
Search
Page Path
HOME
Search
Original Article
High Notch1 Expression Correlates with Tumor Stage and Size in Clear Cell Renal Cell Carcinoma
Jun Nyung Lee, So Young Chun, Hyo Jung Lee, Yun-Sok Ha, Hyun Tae Kim, Eun Sang Yoo, Tae Gyun Kwon, Tae-Hwan Kim
Korean J Urol Oncol.
2016;14(3):130-137. Published online December 31, 2016
DOI:
https://doi.org/10.22465/kjuo.2016.14.3.130
Cited By 3
Full text
PubReader
ePub
PDF
1
Journal of
Urologic Oncology
Print ISSN: 2951-603X
Online ISSN: 2982-7043
MOST READ
MOST CITED
11,240
Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma
11,009
Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians
8,435
Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients
7,634
The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer
7,210
Prognostic Impact of Seminal Vesicle Mucosal Invasion in pT3b Prostate Cancer Following Radical Prostatectomy
+more
Cited By
11
Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion
Cited By
8
Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
Cited By
7
Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Cited By
5
Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians
Cited By
5
Delivering on the Promise of Precision Oncology in Prostate Cancer: Prediagnostic Strategies, Postdiagnostic Applications, and Future Directions. A Narrative Review
+more